Italia markets closed

BMY Jan 2026 50.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,1000+0,1500 (+3,80%)
Alla chiusura: 02:22PM EDT
Schermo intero
Chiusura precedente3,9500
Aperto4,0900
Denaro4,0500
Lettera4,2500
Prezzo d'esercizio50,00
Scadenza2026-01-16
Min-Max giorno4,0700 - 4,1000
Contratto - Min-MaxN/D
Volume195
Open Interest3,65k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri